Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

2 recruiting3 with results

Enrollment reporting

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05562388Not ApplicableCompleted

Mandibular Advancement Device and Changes in Nocturia

Role: lead

NCT03848143Phase 2Completed

Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain

Role: lead

NCT07103941Not ApplicableRecruiting

IOA Preventing Occlusal Changes With MAD Use

Role: lead

NCT07186725Not ApplicableRecruiting

Home-based Under Mattress Monitor for OSA

Role: lead

NCT05139303Not ApplicableCompleted

Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.

Role: lead

All 5 trials loaded